Loading chat...
CA AB2442
Bill
Status
Introduced
2/20/2026
Primary Sponsor
Joe Patterson
Click for details
AI Summary
- Declares legislative intent to create a state-authorized framework for peptide research and investigational therapeutic access under medical supervision
- Addresses peptide compounds that show therapeutic potential but cannot progress through traditional FDA drug approval pathways due to economic, patent, or market limitations
- Targets research expansion in rare diseases, healthy aging/longevity, veteran therapeutics, obesity/metabolic disease, and neurodegenerative conditions
- Proposes institution-level safety oversight and high-quality manufacturing/testing standards for peptides
- This is an intent bill only; contains no substantive regulatory provisions yet and requires no appropriation or fiscal committee review
Legislative Description
Peptides.
Last Action
From printer. May be heard in committee March 23.
2/21/2026
Full Bill Text
No bill text available